NASDAQ:NXGN
NextGen Healthcare
- Stock
Last Close
23.91
08/11 21:00
Market Cap
1.61B
Beta: 1.04
Volume Today
3.12M
Avg: 342.09K
PE Ratio
−258.41
PFCF: −37.06
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 772K - | 728K 5.70% | 588.50K 19.16% | 356.50K 39.42% | 169K 52.59% | 150K 11.24% | 10.23M 6,717.33% | 23.15M 126.34% | 28.55M 23.36% | 19.21M 32.73% | |
average payables | 9.69M - | 8.95M 7.65% | 10.57M 18.08% | 7.87M 25.54% | 4.42M 43.91% | 4.82M 9.22% | 7.98M 65.40% | 10.95M 37.27% | 10.25M 6.37% | 10.57M 3.14% | |
average receivables | 133.40M - | 114.68M 14.03% | 118.77M 3.57% | 106.41M 10.41% | 89.58M 15.81% | 98.73M 10.21% | 98.89M 0.16% | 95.59M 3.34% | 102.75M 7.50% | 110.51M 7.55% | |
book value per share | 4.92 - | 4.71 4.46% | 4.44 5.58% | 4.93 11.07% | 5.10 3.32% | 5.84 14.47% | 6.12 4.81% | 6.47 5.74% | 6.28 2.90% | 5.98 4.84% | |
capex per share | -0.48 - | -0.35 26.83% | -0.47 34.91% | -0.33 30.20% | -0.45 36.84% | -0.40 12.32% | -0.41 3.62% | -0.42 3.43% | -0.42 1.84% | -0.56 33.42% | |
capex to depreciation | -1.00 - | -0.72 27.75% | -0.96 33.60% | -0.50 47.66% | -0.71 40.56% | -0.59 16.61% | -0.56 4.95% | -0.58 2.38% | -0.66 15.25% | -1.02 53.02% | |
capex to operating cash flow | -0.28 - | -0.26 7.40% | -0.70 175.39% | -0.18 73.75% | -0.37 102.77% | -0.51 35.09% | -0.31 37.90% | -0.29 8.40% | -0.52 82.32% | -0.85 62.74% | |
capex to revenue | -0.06 - | -0.04 33.25% | -0.06 35.14% | -0.04 31.24% | -0.05 34.77% | -0.05 10.65% | -0.05 3.16% | -0.05 2.28% | -0.05 7.48% | -0.06 21.15% | |
cash per share | 1.90 - | 2.17 14.10% | 0.60 72.24% | 0.61 1.31% | 0.45 25.38% | 0.51 12.93% | 2.11 310.48% | 1.10 47.90% | 0.89 19.14% | 3.56 300.52% | |
days of inventory on hand | 1.38 - | 1.02 26.42% | 0.90 11.74% | 0.26 71.21% | 0.27 5.24% | 0.18 34.73% | 27.75 15,529.24% | 34.40 23.97% | 38.49 11.87% | 7.76 79.84% | |
days payables outstanding | 13.08 - | 16.39 25.30% | 18.00 9.85% | 7.55 58.03% | 6.37 15.72% | 8.04 26.24% | 14.36 78.66% | 15.08 5.01% | 11.27 25.23% | 12.83 13.79% | |
days sales outstanding | 97.31 - | 82.51 15.21% | 93.93 13.84% | 61.66 34.36% | 63.98 3.77% | 72.00 12.53% | 63.10 12.36% | 64.10 1.59% | 65.93 2.86% | 63.32 3.96% | |
debt to assets | 0.06 - | 0.10 62.52% | 0.23 139.69% | 0.03 85.45% | 0.13 271.33% | 0.07 45.30% | 0.25 259.54% | 0.05 80.47% | 0.03 34.08% | 0.31 861.19% | |
debt to equity | 0.09 - | 0.16 75.02% | 0.46 190.78% | 0.05 88.54% | 0.20 281.72% | 0.10 51.38% | 0.45 356.08% | 0.07 83.78% | 0.05 34.50% | 0.69 1,349.84% | |
dividend yield | 0.04 - | 0.04 6.45% | 0.05 4.40% | ||||||||
earnings yield | 0.02 - | 0.03 83.09% | 0.01 78.43% | 0.02 216.28% | 0.00 85.57% | 0.02 709.83% | 0.01 51.54% | 0.01 28.19% | 0.00 85.42% | -0.00 298.08% | |
enterprise value | 908.67M - | 843.95M 7.12% | 1.00B 18.72% | 920.49M 8.13% | 874.04M 5.05% | 1.06B 21.29% | 723.98M 31.71% | 1.17B 61.04% | 1.37B 17.41% | 1.34B 1.92% | |
enterprise value over ebitda | 22.92 - | 21.29 7.15% | 22.15 4.07% | 12.39 44.06% | 57.92 367.36% | 28.59 50.64% | 28.47 0.42% | 16.63 41.58% | 25.61 53.99% | 25.36 0.95% | |
ev to operating cash flow | 8.73 - | 10.20 16.87% | 24.56 140.83% | 8.32 66.11% | 11.41 37.12% | 21.00 84.03% | 8.46 59.73% | 11.83 39.92% | 25.57 116.03% | 30.75 20.28% | |
ev to sales | 2.04 - | 1.72 15.75% | 2.03 18.17% | 1.81 11.22% | 1.65 8.87% | 2.00 21.71% | 1.34 33.11% | 2.09 56.24% | 2.30 9.63% | 2.06 10.45% | |
free cash flow per share | 1.26 - | 1.02 18.75% | 0.20 80.47% | 1.46 630.53% | 0.76 48.22% | 0.39 48.72% | 0.90 131.53% | 1.05 17.25% | 0.38 64.06% | 0.10 74.74% | |
free cash flow yield | 0.07 - | 0.06 14.18% | 0.01 79.53% | 0.10 630.53% | 0.06 42.18% | 0.02 58.34% | 0.09 272.58% | 0.06 32.37% | 0.02 68.89% | 0.01 69.67% | |
graham net net | 0.89 - | 0.61 30.74% | -2.14 447.88% | -1.07 50.16% | -1.48 38.49% | -0.71 52.10% | -1.55 119.15% | -0.80 48.50% | -0.72 9.92% | -2.52 250.47% | |
graham number | 5.38 - | 6.93 28.69% | 3.05 55.93% | 5.72 87.43% | 2.09 63.45% | 7.07 237.78% | 3.97 43.82% | 4.55 14.73% | 1.84 59.56% | 2.31 25.28% | |
income quality | 6.64 - | 3.03 54.41% | 7.21 138.17% | 6.06 15.93% | 31.65 421.99% | 2.06 93.49% | 11.42 454.01% | 10.35 9.31% | 33.09 219.62% | -16.45 149.71% | |
intangibles to total assets | 0.33 - | 0.31 5.57% | 0.55 79.92% | 0.57 2.60% | 0.62 9.02% | 0.58 6.27% | 0.50 13.37% | 0.54 6.61% | 0.53 0.27% | 0.45 15.39% | |
interest coverage | 85.83 - | -156.33 282.14% | 5.65 103.61% | 8.56 51.61% | 2.19 74.40% | 11.24 412.82% | 10.89 3.08% | 5.94 45.44% | 7.43 25.07% | 2.58 65.31% | |
interest debt per share | 0.45 - | 0.74 64.70% | 2.06 178.87% | 0.31 84.93% | 1.08 246.46% | 0.61 42.99% | 2.76 348.86% | 0.52 81.13% | 0.32 38.56% | 4.19 1,213.04% | |
inventory turnover | 263.98 - | 358.78 35.91% | 406.51 13.30% | 1.41K 247.40% | 1.34K 4.98% | 2.06K 53.21% | 13.15 99.36% | 10.61 19.34% | 9.48 10.61% | 47.05 396.10% | |
invested capital | 0.09 - | 0.16 75.02% | 0.46 190.78% | 0.05 88.54% | 0.20 281.72% | 0.10 51.38% | 0.45 356.08% | 0.07 83.78% | 0.05 34.50% | 0.69 1,349.84% | |
market cap | 1.01B - | 962.94M 4.79% | 924.08M 4.04% | 942.11M 1.95% | 865.89M 8.09% | 1.08B 24.98% | 683.55M 36.84% | 1.21B 76.72% | 1.41B 16.62% | 1.17B 17.19% | |
net current asset value | 110.39M - | 103.08M 6.63% | -77.42M 175.11% | -21.38M 72.39% | -50.68M 137.10% | 2.90M 105.73% | -59.61M 2,154.00% | -5.20M 91.28% | 6.97M 234.17% | -93.84M 1,445.61% | |
net debt to ebitda | -2.59 - | -3.00 15.78% | 1.72 157.33% | -0.29 116.91% | 0.54 285.69% | -0.60 210.17% | 1.59 367.02% | -0.60 137.78% | -0.74 23.98% | 3.33 546.63% | |
net income per share | 0.26 - | 0.45 73.32% | 0.09 79.43% | 0.30 216.28% | 0.04 87.07% | 0.38 896.72% | 0.11 69.88% | 0.14 24.50% | 0.02 83.15% | -0.04 264.92% | |
operating cash flow per share | 1.74 - | 1.37 20.98% | 0.67 51.01% | 1.79 165.90% | 1.21 32.51% | 0.78 35.10% | 1.31 66.85% | 1.48 12.91% | 0.79 46.16% | 0.65 18.02% | |
payables turnover | 27.91 - | 22.28 20.19% | 20.28 8.97% | 48.32 138.28% | 57.33 18.65% | 45.42 20.78% | 25.42 44.03% | 24.21 4.77% | 32.37 33.74% | 28.45 12.12% | |
receivables turnover | 3.75 - | 4.42 17.94% | 3.89 12.16% | 5.92 52.34% | 5.70 3.64% | 5.07 11.13% | 5.78 14.11% | 5.69 1.56% | 5.54 2.78% | 5.76 4.13% | |
research and ddevelopement to revenue | 0.09 - | 0.14 51.25% | 0.13 5.60% | 0.15 15.30% | 0.15 0.45% | 0.15 0.02% | 0.15 0.73% | 0.14 12.06% | 0.13 5.20% | 0.13 1.98% | |
return on tangible assets | 0.05 - | 0.09 64.05% | 0.02 72.16% | 0.09 273.73% | 0.01 86.19% | 0.11 789.05% | 0.02 80.88% | 0.03 51.95% | 0.01 82.59% | -0.01 197.64% | |
revenue per share | 7.42 - | 8.14 9.62% | 8.12 0.16% | 8.24 1.50% | 8.37 1.54% | 8.21 1.87% | 8.25 0.44% | 8.34 1.12% | 8.85 6.10% | 9.75 10.12% | |
roe | 0.05 - | 0.10 81.41% | 0.02 78.21% | 0.06 184.75% | 0.01 87.49% | 0.07 770.71% | 0.02 71.26% | 0.02 17.74% | 0.00 82.65% | -0.01 273.30% | |
roic | 0.05 - | 0.08 71.55% | 0.02 80.03% | 0.06 286.51% | -0.11 270.79% | 0.06 157.91% | 0.06 6.91% | 0.04 27.27% | 0.01 82.73% | -0.01 295.69% | |
sales general and administrative to revenue | 0.34 - | 0.32 3.85% | 0.32 1.68% | 0.32 1.21% | |||||||
shareholders equity per share | 4.92 - | 4.71 4.46% | 4.44 5.58% | 4.93 11.07% | 5.10 3.32% | 5.84 14.47% | 6.12 4.81% | 6.47 5.74% | 6.28 2.90% | 5.98 4.84% | |
stock based compensation to revenue | 0.01 - | 0.01 26.48% | 0.01 5.53% | 0.01 122.83% | 0.02 55.32% | 0.03 31.40% | 0.04 19.80% | 0.04 11.88% | 0.04 9.17% | 0.05 15.05% | |
tangible asset value | 150.12M - | 141.88M 5.49% | -24.39M 117.19% | 36.33M 248.96% | 4.13M 88.64% | 66.72M 1,517.18% | 38.52M 42.28% | 86.26M 123.95% | 87.61M 1.56% | -4.80M 105.48% | |
tangible book value per share | 2.51 - | 2.35 6.02% | -0.40 117.08% | 0.59 246.11% | 0.07 88.93% | 1.04 1,492.53% | 0.59 43.21% | 1.29 119.71% | 1.30 0.61% | -0.07 105.51% | |
working capital | 136.47M - | 124.97M 8.43% | 45.93M 63.25% | 18.11M 60.58% | 7.07M 60.96% | 31.62M 347.23% | 116.80M 269.39% | 27.01M 76.87% | 30.71M 13.69% | 203.71M 563.38% |
All numbers in USD (except ratios and percentages)